Glatt

Activities: Manufacturing Nutraceutical

Trending Articles

  1. IMed Consultancy helps Toby Orthopaedics navigate UK regulations Regulatory consultancy ensures compliance and confidence for Miami-based company
  2. Sanofi invests €40m into biopharmaceutical manufacturing at its Lyon Gerland site The pharma giant has expanded its French monoclonal antibody production capabilities, while also dedicating €25m to the development of a second-gen polyclonal antibody
  3. Samsung Biologics bags $668 manufacturing deal with European pharmaceutical company The CDMO will be responsible for the manufacture of the client's biopharmaceuticals until December 2031
  4. IMed supports K2 medical systems in their EU MDR transition Consultancy firm helps K2 navigate the complex regulatory process to achieve Article 97 compliance
  5. Sartorius Stedim Biotech supports bioprocess development with new Innovation Centre The Massachusetts, US-based Centre for Bioprocess Innovation is a collaborative space designed to develop and optimise biomanufacturing processes

Upcoming event

CPhI India

26–28 November 2024 | Online Conference & Networking | Delhi, India See all

Related Content

Manufacturing

Glatt at ACHEMA 2024: process solutions for the pharma industry

The company will showcase a range of solutions in Hall 3.1, Stand A20.
Manufacturing

Auction of equipment: unused Glatt GCC 250 Aqueous Tablet Coating Machine

View this high-quality pharmaceutical equipment in pristine condition
Manufacturing

The design and modularisation of API synthesis plants

The pharmaceutical industry is constantly developing new and more efficient active pharmaceutical ingredients (APIs). To make these available to patients, new production facilities or the expansion of existing ones are often necessary, explains Dirk Steinhäuser from Glatt Process & Plant Engineering
Manufacturing

Topping-out ceremony for the world's first AI-enhanced drug production facility

Glatt is system integrator for a Bayer investment of around 275 million euros
Design & Build

Glatt wins biorefinery engineering project in Thailand

NSTDA Thailand has contracted Glatt for the conceptual and basic design phases for a GMP biorefinery
Manufacturing

The modularisation of chemical API synthesis

The modularisation of chemical synthesis pathways in pharmaceutical production can improve overall plant efficiency and reduce planning time. Glatt Ingenieurtechnik has optimised the active pharmaceutical ingredient (API) synthesis process and developed bespoke plant designs for several international customers
Manufacturing

Plug, play and agglomerate

Glatt will display its continuous compact system at POWTECH India
Subscribe now